Beech Tree Labs Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
2ndary - Private
Beech Tree Labs General Information
Description
Developer of therapeutic agents designed to address a spectrum of unmet medical needs. The company's therapeutic agents have an extensive portfolio of patented formulations for products that treat such disorders as urinary incontinence, allergies, benign prostatic hypertrophy, anxiety, chronic obstructive pulmonary disease, and herpesvirus infections, enabling clients to discover early-stage development of these agents which can then be licensed to the appropriate company.
Contact Information
Website
www.beechtreelabs.comCorporate Office
- 1 Virginia Avenue
- Suite 103
- Providence, RI 02905
- United States
Beech Tree Labs Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Secondary Transaction - Private | 01-Nov-2022 | 000.00 | Completed | Clinical Trials - Phase 2 | ||
5. Later Stage VC (Series C) | 24-Sep-2015 | 00000 | 000.00 | Completed | Clinical Trials - Phase 2 | |
4. Later Stage VC (Series B) | 16-Nov-2010 | 00.000 | 000.00 | 000.00 | Completed | Clinical Trials - Phase 2 |
3. Grant | 01-Nov-2010 | 00000 | 00.000 | Completed | Clinical Trials - Phase 2 | |
2. Seed Round | 15-Mar-2010 | $1.46M | $8.46M | Completed | Clinical Trials - Phase 2 | |
1. Angel (individual) | 02-Nov-2006 | $7M | $7M | 0000 | Completed | Clinical Trials - Phase 2 |
Beech Tree Labs Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
Series A | 0,000,000 | 00.000000 | 00.00 | 00 | 00 | 00 | 00 | 00.00 |
Beech Tree Labs Patents
Beech Tree Labs Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4126034-A1 | Method of treating coronavirus infection by administration of ethyl mercury or thiol derivative thereof | Inactive | 27-Mar-2020 | 0000000000 | |
US-20230398090-A1 | Method of treating coronavirus infection by administration of ethyl mercury or thiol derivative thereof | Pending | 27-Mar-2020 | 0000000000 | |
US-20180028602-A1 | Method of inhibiting microglial cell migration and treating traumatic brain injury | Active | 08-Apr-2015 | 0000000000 | |
US-10213480-B2 | Method of inhibiting microglial cell migration and treating traumatic brain injury | Active | 08-Apr-2015 | 0000000000 | 00 |
AU-2016246713-B2 | Methods of treating a traumatic brain injury | Active | 08-Apr-2015 | A61K38/164 | 0 |
Beech Tree Labs Executive Team (3)
Beech Tree Labs Board Members (9)
Name | Representing | Role | Since |
---|---|---|---|
Doug Hulse | Self | Board Member | 000 0000 |
John Glasson ESQ | Beech Tree Labs | Board Member | 000 0000 |
John McMichael Ph.D | Beech Tree Labs | Founder, Chief Executive Officer, President, and Board Member | 000 0000 |
Beech Tree Labs Signals
Beech Tree Labs FAQs
-
When was Beech Tree Labs founded?
Beech Tree Labs was founded in 2004.
-
Who is the founder of Beech Tree Labs?
John McMichael Ph.D is the founder of Beech Tree Labs.
-
Who is the CEO of Beech Tree Labs?
John McMichael Ph.D is the CEO of Beech Tree Labs.
-
Where is Beech Tree Labs headquartered?
Beech Tree Labs is headquartered in Providence, RI.
-
What is the size of Beech Tree Labs?
Beech Tree Labs has 2 total employees.
-
What industry is Beech Tree Labs in?
Beech Tree Labs’s primary industry is Drug Discovery.
-
Is Beech Tree Labs a private or public company?
Beech Tree Labs is a Private company.
-
What is Beech Tree Labs’s current revenue?
The current revenue for Beech Tree Labs is 000000.
-
How much funding has Beech Tree Labs raised over time?
Beech Tree Labs has raised $15.2M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »